Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000615542 | SCV000728342 | likely benign | not specified | 2018-03-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Mayo Clinic Laboratories, |
RCV002261128 | SCV002541954 | uncertain significance | not provided | 2021-07-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413756 | SCV002715663 | likely benign | Cardiovascular phenotype | 2020-08-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004735672 | SCV005359266 | uncertain significance | TTN-related disorder | 2024-04-09 | no assertion criteria provided | clinical testing | The TTN c.44497G>A variant is predicted to result in the amino acid substitution p.Val14833Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.051% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-179490051-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |